Literature DB >> 18417026

Occipital nerve stimulation for medically intractable headache.

Todd J Schwedt1.   

Abstract

There is an unmet need, and thus a continued search, for effective treatments for patients with chronic daily headache who do not respond to or tolerate conventional therapies. Recent interest has focused on the use of occipital nerve stimulation (ONS) to treat patients with chronic, disabling headaches who are not adequately controlled by usual therapies. A small but growing body of evidence supports the use of ONS for the treatment of intractable headache. Electrical stimulation of the occipital nerve has both peripheral and central nervous system effects that modulate nociception. The exact role for ONS will evolve as our understandings of its physiologic effects, efficacy, and safety grow.

Entities:  

Mesh:

Year:  2008        PMID: 18417026     DOI: 10.1007/s11916-008-0012-7

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  21 in total

1.  Direct effect of electrical stimulation on peripheral nerve evoked activity: implications in pain relief.

Authors:  R J Ignelzi; J K Nyquist
Journal:  J Neurosurg       Date:  1976-08       Impact factor: 5.115

2.  C2 and C3 pain dermatomes in man.

Authors:  C E Poletti
Journal:  Cephalalgia       Date:  1991-07       Impact factor: 6.292

3.  Stimulation of the greater occipital nerve increases metabolic activity in the trigeminal nucleus caudalis and cervical dorsal horn of the cat.

Authors:  P J Goadsby; Y E Knight; K L Hoskin
Journal:  Pain       Date:  1997-10       Impact factor: 6.961

Review 4.  Pain mechanisms: a new theory.

Authors:  R Melzack; P D Wall
Journal:  Science       Date:  1965-11-19       Impact factor: 47.728

5.  Referred pain after painful stimulation of the greater occipital nerve in humans: evidence of convergence of cervical afferences on trigeminal nuclei.

Authors:  E J Piovesan; P A Kowacs; C E Tatsui; M C Lange; L C Ribas; L C Werneck
Journal:  Cephalalgia       Date:  2001-03       Impact factor: 6.292

6.  Occipital nerve electrical stimulation via the midline approach and subcutaneous surgical leads for treatment of severe occipital neuralgia: a pilot study.

Authors:  Leonardo Kapural; Nagy Mekhail; Salim M Hayek; Michael Stanton-Hicks; Osama Malak
Journal:  Anesth Analg       Date:  2005-07       Impact factor: 5.108

7.  Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input.

Authors:  Thorsten Bartsch; Peter J Goadsby
Journal:  Brain       Date:  2002-07       Impact factor: 13.501

8.  Peripheral neurostimulation for the treatment of chronic, disabling transformed migraine.

Authors:  Charles A Popeney; Kenneth M Aló
Journal:  Headache       Date:  2003-04       Impact factor: 5.887

9.  Peripheral nerve stimulation for the treatment of occipital neuralgia and transformed migraine using a c1-2-3 subcutaneous paddle style electrode: a technical report.

Authors:  Michael Y Oh; Juan Ortega; J Bradley Bellotte; Donald M Whiting; Kenneth Aló
Journal:  Neuromodulation       Date:  2004-04

10.  Stimulation ranges, usage ranges, and paresthesia mapping during occipital nerve stimulation.

Authors:  Terrence L Trentman; Richard S Zimmerman; Nikesh Seth; Joseph G Hentz; David W Dodick
Journal:  Neuromodulation       Date:  2008-01
View more
  5 in total

1.  Treatment of hemicrania continua by occipital nerve stimulation with a bion device.

Authors:  Julio Pascual
Journal:  Curr Pain Headache Rep       Date:  2009-02

Review 2.  Role of trigeminal microvascular decompression in the treatment of SUNCT and SUNA.

Authors:  Swapna Sebastian; Daniel Schweitzer; Leong Tan; Simon A Broadley
Journal:  Curr Pain Headache Rep       Date:  2013-05

3.  Supraorbital transcutaneous neurostimulation has sedative effects in healthy subjects.

Authors:  Maxime Piquet; Costantino Balestra; Simona L Sava; Jean E Schoenen
Journal:  BMC Neurol       Date:  2011-10-28       Impact factor: 2.474

4.  Transcutaneous Supraorbital Nerve Stimulation (t-SNS) with the Cefaly® Device for Migraine Prevention: A Review of the Available Data.

Authors:  Franz Riederer; Sophie Penning; Jean Schoenen
Journal:  Pain Ther       Date:  2015-10-14

5.  Refractory chronic migraine: a consensus statement on clinical definition from the European Headache Federation.

Authors:  Paolo Martelletti; Zaza Katsarava; Christian Lampl; Delphine Magis; Lars Bendtsen; Andrea Negro; Michael Bjørn Russell; Dimos-Dimitrios D Mitsikostas; Rigmor Højland Jensen
Journal:  J Headache Pain       Date:  2014-08-28       Impact factor: 7.277

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.